Account
Wipro appoints OMD India to manage media mandate
MUMBAI: Wipro Consumer Care has appointed OMD India to manage its media duties.
The account will be serviced by a dedicated team of media, strategy and data specialists out of the network’s Bengaluru office. The scope of work covers the planning and buying duties for both offline and digital channels for all of Wipro’s iconic brands – Yardley, Glucovita and Safewash – as well as any future product launches targeting urban consumers.
The accounts were previously managed by Wavemaker, which held the business for the past five years.
Wipro Consumer Care is among the top FMCG and the fastest-growing companies in India, with its products sold in over 40 countries worldwide. Having established a strong consumer base for its personal and skin care products in South-East Asia and the Middle East, Wipro has also gained a global footprint by acquiring Singapore’s Unza Holdings and LD Waxsons, and Yardley’s businesses in India, Middle East, UK and Europe.
OMD India CEO Priti Murthy mentions, “We are delighted to have the opportunity to work with Wipro and its amazing portfolio of brands. This collaboration will give us the opportunity to create interesting, challenging and effective work in the constantly changing marketing and media ecosystem. By leveraging our deep analytical capabilities, performance-based media channels and media creativity, we are well prepared to drive tangible business results and growth for Wipro.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
